DIDO 3 [SpacePharma]
The DIDO satellites are 3U CubeSat satellites for micro-gravity rersearch designed by the Israeli / Swiss company SpacePharma.
The satellites contain the mGnify miniaturized end-to-end lab, that can be remote controlled from anywhere. The mGnify unit can perform experiments on bacterial growth, antibiotics resistance, self-assembly, enzymatic reactions, polymerization, nanoparticle synthesis, particle aggregation dynamics, emulsion stability and crystallization.
Upgrades have been made to the DIDO-3 platform to be able to support dedicating more power to the payload, allowing it to maintain higher temperatures than the previous mission, DIDO-2.
A third mission, DIDO 3, was ordered in 2018. It is to fly in 2019 on a multi satellite launch on a Vega rocket.
Nation: | Israel, Switzerland |
---|---|
Type / Application: | Micro-gravity research |
Operator: | SpacePharma |
Contractors: | ISIS, SpacePharma |
Equipment: | mGnify lab |
Configuration: | CubeSat (3U) |
Propulsion: | None |
Power: | Solar cells, batteries |
Lifetime: | |
Mass: | 4 kg |
Orbit: | 534 km × 536 km, 97.52° (#3) |
Satellite | COSPAR | Date | LS | Launch Vehicle | Remarks | |
---|---|---|---|---|---|---|
DIDO 3 | 2020-061N | 03.09.2020 | Ko ELV | Vega | with Athena, ION-SCV 1, ESAIL, UPMSat 2, NEMO-HD, ŃuSat 6, GHGSat C1, Flock-4v 1, ..., 26, Lemur-2 112, ..., 119, SpaceBEE 10, ..., 21, FSSCat A, B, NAPA 1, TARS, EG 2, OSM 1 CICERO, PICASSO, SIMBA, TRISAT, AMICal-Sat, TTÜ100 |